Skip to main content
. 2016 Dec 20;72(2):522–528. doi: 10.1093/jac/dkw499

Figure 1.

Figure 1

Principal coordinate analysis (PCoA) of faecal samples. (a) Three individual post-FMT patients treated with gentamicin. Each patient submitted three samples, one before gentamicin and two during or after treatment. (b) The same samples (as in a) from the three patients are shown within the principal coordinate analysis that contains pre-FMT (red crosses) and post-FMT (grey circles) faecal samples from patients who did not get any new antibiotics after FMT and one patient who received piperacillin/tazobactam shortly after her FMT (blue crosses). (c) The same samples (as in a) from the three patients are shown within the principal coordinate analysis that contains pre-FMT faecal samples (red crosses) and healthy donors (grey circles). This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.